Navigation Links
HUYA Bioscience Int'l Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
Date:6/17/2008

nic arrhythmia.

Most existing marketed and development-stage anti-arrhythmics have been associated with adverse events such as Torsade de Pointes (TdP - sudden death) or appreciable QTc prolongation (a risk factor for sudden death) in Phase I or preclinical studies. As noted above, in the preclinical studies and the three Phase I studies completed in China, HBI-3000 was well tolerated.

Atrial Fibrillation (AF) is a serious type of arrhythmia found in approximately 2.2 million Americans and about 15 percent of strokes occur in people with AF(1). Ventricular Arrhythmia (VA), a severely abnormal heart rhythm, will cause death unless treated immediately. Ventricular fibrillation (VF), a type of arrhythmia, is responsible for 75 to 85 percent of sudden deaths in persons with heart problems(2).

Currently, anti-arrhythmic drugs are commonly used to treat patients with AF and VA, though in treating patients with VA, most anti-arrhythmics have failed to demonstrate a survival advantage. In some cases they may also carry safety risks, including sudden death. Pre-clinical data developed by HUYA and its Chinese partner, along with the Chinese clinical trial data are encouraging to suggest that HBI-3000 may have a useful role in the treatment of ventricular arrhythmias.

In the United States, HBI-3000 is initially being developed and investigated for use as IV treatment of atrial fibrillation with clinical trials expected to begin in early 2009. "This is a significant area of medicine for which providers need more options to treat patients," continued Gingras. "Researchers in China are developing promising compounds that would fulfill these and other unmet medical needs in the U.S. As we prepare to assemble the data and submit our IND to initiate the Phase I trials, we'll continue to leverage our collaboration and expertise in China and the U.S. It's exciting to think of the amount of time and funding that could be saved by optimizing and streamlining
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
2. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
3. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
6. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
7. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
10. Neurocrine Biosciences Reports First Quarter 2008 Results
11. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Aug. 30 The rate of electronic health record ... the next two to five years due to a ... provided by the U.S. government,s HITECH program have also ... (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...
... Memorial Hospital—a not-for-profit, 108-bed hospital in Eden, N.C.—has ... through real-time clinical surveillance and instant access to ... award-winning mobile data system, gathers clinical data from ... patient data to any caregiver at the point-of ...
Cached Medicine Technology:U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan 2U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan 3Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus 2
(Date:4/24/2014)... and health maps at a fine scale across England ... Area Health Statistics Unit (SAHSU), part of the MRC-PHE ... London, the open-access atlas allows researchers, policy makers and ... of 14 diseases and conditions such as lung cancer, ... Alongside this it provides maps of geographical variations of ...
(Date:4/24/2014)... Orange, NJ. April 24, 2014. Nancy Chiaravalloti, PhD, ... by Saint Peter,s University in Jersey City, New Jersey. ... University,s Pope Lecture Hall on the topic of "Treating ... "It is an honor to be a part of ... Saint Peter,s University," said Dr. Chiaravalloti. "The field of ...
(Date:4/24/2014)... since it was first identified more than 15 years ... an integral role in preventing the onset and progression ... or mutated, malignant cells can grow unchecked and cancer ... at Beth Israel Deaconess Medical Center (BIDMC) helps explain ... how its loss or alteration can set cells on ...
(Date:4/24/2014)... giving scientists a better understanding of drug interactions, which ... , When two or more medications are taken ... the effectiveness of the other. Similarly, one drug ... interactions are a major cause of illness and hospitalization. ... practical scope of drug studies in humans. Limits ...
(Date:4/24/2014)... often coexist with the negative and stressful outcomes for ... diagnosed with a life-limiting illness, says a recent study ... , While the challenges are numerous and life-changing and ... participated in the Waterloo-led research reported positive outcomes as ... appear in the most recent issue of the ...
Breaking Medicine News(10 mins):Health News:New high-detail atlas offers tool to explore local environment and health 2Health News:New high-detail atlas offers tool to explore local environment and health 3Health News:Kessler Foundation scientist named 63rd Mendel Lecturer by St. Peter's University 2Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Parents of severely ill children see benefits as caregivers, says study 2
... officials desire quick-response emergency capability to treat ... suspected and known cyanide poisoning ... today announced that the,Florida Department of Health, Office of ... for Cyanide,Poisoning in the State,s emergency medical service (EMS) ...
... Physiology and Exercise Metabolism (Montana WPEM) will present a ... American College of Sports Medicine, showing that wildland ... supplement, Wellmune WGP, had far fewer 23 ... similar group of firefighters taking a placebo. , Montana ...
... Italy, 29 May 2008 - Patients suffering from hemineglect ... to their left side. However, sometimes these ignored stimuli ... in the May 2008 issue of Cortex, Jerome Sackur ... reported that unconscious processing in hemineglect is not limited ...
... Amerifit Brands Educates Consumers about Urinary Health, CROMWELL, Conn., ... tract infections (UTIs) are the second most common type,of infection ... doctor visits,each year. One-third of women will be diagnosed with ... women will get at least one in their lifetime.(2),However, many ...
... BOSTON, May 29 The Global Business and ... senior business,executives and clinical scientific leaders, will host a ... The forum is the third,in a series of four ... well being of employees and their families., The ...
... beer, liquor had opposite effect , , THURSDAY, May 29 ... may not only be safe for the liver, but ... disease (NAFLD), according to a new study that challenges ... the University of California, San Diego, included 7,211 nondrinkers ...
Cached Medicine News:Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 2Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 3Health News:Montana Center for Work Physiology and Exercise Metabolism presents firefighter health study 2Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 2Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 3Health News:Mental Health & Addiction Among Working Parents & Children Affects the Bottom Line: Research Shows Staggering Economic Impact 4Health News:Daily Glass of Wine Cut Risk of Fatty Liver Disease 2
... Multi frequency and multigate ... detection and fitted with ... tests for hemodynamic evaluation. ... as well for routine ...
The Spencer Technologies PMD 100 (TCD 100M) is the worlds first stand-alone digital transcranial doppler system....
Swiss Watchmaker Forceps, 4" extra-long precision ground points....
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
Medicine Products: